Lipid lowering medication and hepatotoxicity

被引：13

作者：

Kinnman, N ^{[1
]}

Hultcrantz, R ^{[1
]}

机构：

[1] Karolinska Hosp, Dept Gastroenterol & Hepatol, S-17676 Stockholm, Sweden

来源：

JOURNAL OF INTERNAL MEDICINE | 2001年 / 250卷 / 03期

关键词：

D O I：

10.1046/j.1365-2796.2001.00887.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：183 / 185

页数：3

相关论文

共 13 条

[1] Use and monitoring of "statin" lipid-lowering drugs compared with guidelines
Abookire, SA
Karson, AS
Fiskio, J
Bates, DW
[J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) : 53 - 58
[2] Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia
Athyros, VG
Papageorgiou, AA
Hatzikonstandinou, HA
Didangelos, TP
Carina, MV
Kranitsas, DF
Kontopoulos, AG
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (05) : 608 - 613
[3] Hepatotoxicity in drug development: Detection, significance and solutions
Ballet, F
[J]. JOURNAL OF HEPATOLOGY, 1997, 26 : 26 - 36
[4] BENICHOU C, 1990, J HEPATOL, V11, P272
[5] BERNARD PH, 1994, GASTROEN CLIN BIOL, V18, P1048
[6] Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients
Boffa, MJ
Smith, A
Chalmers, RJG
Mitchell, DM
Rowan, B
Warnes, TW
Shomaf, M
Haboubi, NY
[J]. BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (04) : 538 - 544
[7] CHATRENET P, 1993, GASTROEN CLIN BIOL, V17, P612
[8] Dumortier J, 1999, GASTROEN CLIN BIOL, V23, P1399
[9] Farrell GC., 1994, DRUG INDUCED LIVER D
[10] Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
Friedman, SL
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) : 2247 - 2250